SHDMF Shoppers Drug Mart Corp featured news, full reports, and detailed charts
Shoppers Drug Mart Corp (SHDMF/SHDMF.PK) Wrap Up:
Shoppers Drug Mart Corporation, together with its subsidiaries, licenses full-service retail drug stores operating under the names Shoppers Drug Mart and Pharmaprix in Canada. Its stores offer over-the-counter medications, health and beauty aids, cosmetics and fragrances, seasonal products, and everyday household essentials. The company provides a range of private label products marketed under various trademarks, including Life Brand, Quo, Everyday Market, Bio-Life, Nativa, Get, and Easypix. As of February 12, 2009, it had approximately 1,149 Shoppers Drug Mart and Pharmaprix stores. The company also offers the HealthWATCH program, which provides patient counseling on medications, disease management, and health and wellness, as well as the Shoppers Optimum program, a retail loyalty card program. In addition, Shoppers Drug Mart Corporation owns and operates 65 Shoppers Home Health Care stores that are engaged in the sale and service of assisted-living devices, medical equipment, home-care products, and mobility equipment to institutional and retail customers. Further, it provides specialty drug distribution, pharmacy, and patient support services; and pharmaceutical products and services to long-term care facilities in Ontario and Alberta. Shoppers Drug Mart Corporation was founded in 1962 and is based in Toronto, Canada.Shoppers Drug Mart Corp (SHDMF:OTC)
|
Market Cap
8.8B
|
Total Revenue
10.0B
|
|
|
EBITDA
1.1B
|
DILUTED EPS TTM
2.72
|
|
|
P/E
15.5x
|
P/S
0.9x
|
|
|
Return On Asset
8.93
|
Return On Equity
16.82
|
|
| K = Thousands M = Millions B = Billions | ||
SHDMF Top Compensated Officers
Executives, Board Directors
Key developments for Shoppers Drug Mart Corp (SHDMF)
Shoppers Drug Mart Corp. announced unaudited consolidated earnings results for the third quarter and nine months ended October 10, 2009. For the quarter, the company reported EBITDA of CAD 341,218,000, operating income of CAD 262,649,000, earnings before income tax of CAD 244,589,000 and net earnings of CAD 170,894,000 or CAD 0.79 diluted share on sales of CAD 3,013,007,000 compared with EBITDA of CAD 316,246,000, operating income of CAD 252,447,000, earnings before income tax of CAD 232,347,000 and net earnings of CAD 160,276,000 or CAD 0.74 diluted share on sales of CAD 2,793,005,000 for the same period a year ago. The company's capital investment program, which has resulted in an 11.6% increase in drug store selling space compared to a year ago, continues to have a positive impact on sales growth. Effective marketing campaigns, combined with differentiated and impactful promotions utilizing the Shoppers Optimum loyalty card program, also contributed to top-line growth. This increase in net earnings was driven by strong sales growth, improved purchasing synergies and a continued emphasis on cost reduction, productivity and efficiency, the benefits of which were partially offset by increased amortization and higher expenses at store-level associated with the continued expansion of the store network, along with stepped-up investments in pricing and promotional activities. Third quarter capital expenditure program of CAD 178 million compared to CAD 273 million in the prior year. Included in the prior year was the acquisition of the assets of the HealthAccess division of Calea Ltd. and 100% of the shares of Calea Ltd.'s wholly-owned subsidiary, Information Healthcare Marketing Corp. (CAD 89 million). Opened or acquired 37 new drug stores, 15 of which were relocations, and added two Murale(TM) luxury beauty stores. Cash flows from operating activities were CAD 239 million in the third quarter of 2009 compared to CAD 165 million in the same period last year. For the nine months, the company reported EBITDA of CAD 830,695,000, operating income of CAD 640,244,000, earnings before income tax of CAD 593,797,000 and net earnings of CAD 413,848,000 or CAD 1.90 diluted share on sales of CAD 7,497,056,000 compared with EBITDA of CAD 766,066,000, operating income of CAD 611,172,000, earnings before income tax of CAD 563,160,000 and net earnings of CAD 387,609,000 or CAD 1.78 diluted share on sales of CAD 6,926,112,000 for the same period a year ago. Year-to-date capital expenditure program of CAD 418 million compared to CAD 517 million in the prior year. Opened or acquired 104 new drug stores, 37 of which were relocations, and added two Murale(TM) luxury beauty stores. For the period, the company reported net debt of CAD 1,402,072,000 compared with CAD 1,389,315,000 for the period ended on January 03, 2009. Year-to-date, the Company has generated CAD 521 million of cash from operating activities compared to CAD 318 million in the first three quarters of 2008. The company announced that its Board of Directors has declared a dividend of 21.5 cents per common share, payable January 15, 2010 to shareholders of record as of the close of business on December 31, 2009.
Shoppers Drug Mart Corp. announced that on October 29th, 2009, it will unveil its innovative and new retail beauty store, Murale, in Vancouver with a media preview and VIP customer event. The store opens to the public on October 30th, 2009 in Oakridge Centre. The beauty store will feature an unprecedented assortment of luxury, dermatological, fragrance and niche brands from around the world. Upon entering the store, customers will be delighted by the assortment of global luxury prestige cosmetics brands including Bobbi Brown, Chanel, Yves Saint Laurent, Estee Lauder, Lancome, Stila and Nars, among others, each with their own area for interactivity and application. The store's fragrance section includes over 75 men's and women's scents from fragrance houses and designers like Prada, Donna Karan, Chloe, Cartier and Etat Libre d'Orange. Offering personalized and unbiased beauty advice, Murale Beauty Masters will assist customers in finding cosmetics and fragrances suited to their needs and also provide expert makeup applications. Murale's sophisticated dermatological area is equipped with professional assessment tools and the latest in topical treatments and nutra-cosmetics. With an assortment that delivers excellence in skin care, Murale will feature trusted and innovative brands like Natura Bisse, Vichy, Dr. Brandt, June Jacobs, and Darphin. Murale's professional skin care team, comprised of the store's Beauty Masters and an Aesthetician, is focused on personalized consultation.
Shoppers Drug Mart Corp. announced that expanding its already impressive cache of exclusive brands, the company unveils Balea(R), a new line of health and beauty lifestyle products that offer both quality and affordability. Balea invites shoppers to experience the brand 'from head to toe,' with a comprehensive range of products that includes hair care and skin care for the whole body, from facial wipes and lip balms to shampoos, body lotions and foot creams. Balea is available exclusively at more than 1,160 Shoppers Drug Mart and Pharmaprix stores across Canada, a convenience that fits in with Canadians' increasingly busy, active lifestyles. The new line will boast more than 130 items to choose from by the end of 2009, with hundreds more to follow in 2010.
SHDMF Competitors
| Company | Last | Change |
| Aim Health Group Inc | C$0.12 CAD | -0.01 |
| Wex Pharmaceuticals Inc | C$0.18 CAD | 0.00 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | SHDMF | Industry Range |
| Price/Earnings | 15.5x |
|
| Price/Sales | 0.9x |
|
| Price/Book | 2.5x |
|
| Price/Cash Flow | 11.0x |
|
| TEV/Sales | 0.8x |
|
|
SHDMF |
||
SHDMF transactions
| Type Date |
Target |
|
Merger/Acquisition
November 16, 2009 |
Shoppers Drug Mart Corp., 12 Retail Properties Across Canada |
